Spinogenix
San Diego
About Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. The company is focused on regenerating synapses to reverse declines in cognitive and motor function. They envision the use of SPGs as a monotherapy or in combination with other therapeutics that target disease-specific degenerative processes. Spinogenix's mission is to create transformative therapeutics for diseases involving synaptic loss and dysfunction. It was founded in 2016 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Last round: Series Unknown (Mar 2026)
- Website: spinogenix.com
- Phone: 858-263-3252
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spinogenix-104301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.